Free Trial

Proficio Capital Partners LLC Takes Position in Solventum Co. (NYSE:SOLV)

Solventum logo with Medical background
Remove Ads

Proficio Capital Partners LLC acquired a new stake in Solventum Co. (NYSE:SOLV - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 23,385 shares of the company's stock, valued at approximately $1,545,000.

Several other hedge funds also recently bought and sold shares of SOLV. New York Life Investment Management LLC raised its holdings in shares of Solventum by 0.7% in the 4th quarter. New York Life Investment Management LLC now owns 18,506 shares of the company's stock valued at $1,223,000 after acquiring an additional 136 shares in the last quarter. Apriem Advisors purchased a new stake in Solventum in the fourth quarter valued at approximately $333,000. Bank of New York Mellon Corp lifted its holdings in shares of Solventum by 4.1% during the 4th quarter. Bank of New York Mellon Corp now owns 943,699 shares of the company's stock worth $62,341,000 after acquiring an additional 36,907 shares during the last quarter. Fisher Funds Management LTD bought a new position in Solventum in the fourth quarter valued at $709,000. Finally, Wolverine Asset Management LLC bought a new position in Solventum in the fourth quarter valued at $11,296,000.

Analyst Ratings Changes

SOLV has been the subject of a number of research reports. Bank of America upped their price objective on Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a report on Wednesday, February 26th. Mizuho lifted their target price on shares of Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. Piper Sandler upped their price target on shares of Solventum from $75.00 to $84.00 and gave the company a "neutral" rating in a research report on Friday, February 28th. Wells Fargo & Company lifted their price objective on Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a report on Friday, February 28th. Finally, Morgan Stanley raised their price target on Solventum from $73.00 to $80.00 and gave the stock an "equal weight" rating in a research report on Wednesday, March 5th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $79.86.

Remove Ads

View Our Latest Report on Solventum

Solventum Trading Down 0.3 %

NYSE SOLV traded down $0.21 on Monday, hitting $77.73. The company's stock had a trading volume of 1,604,126 shares, compared to its average volume of 1,049,530. The firm has a market cap of $13.45 billion and a P/E ratio of 28.26. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $96.05. The company's 50-day simple moving average is $73.65 and its 200 day simple moving average is $70.71. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Solventum Profile

(Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Further Reading

Institutional Ownership by Quarter for Solventum (NYSE:SOLV)

Should You Invest $1,000 in Solventum Right Now?

Before you consider Solventum, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.

While Solventum currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Institutions Are Dumping These 3 Stocks—Should You?
Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads